Suzetrigine for Analgesiain Arthroscopic Rotator Cuff Repair

The requested reference [7db227378607a71b8648835031a4f6526b3922f5] no longer exists in our database. It has been replaced by the current reference: [eb0e95abd91ca95e32b3f24b19f7cb4979bc1240]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this prospective is to determinate if Suzetrigine decreased de use of opioids in patients that undergo an arthroscopic rotator cuff repair. The main question it aims to answer: Does Suzetrigine lower the number of times participants need to use opioid? If there is a comparison group: Researchers will compare study drug group to see if, will reduce opioid utilization during the inpatient period and at discharge without worsening pain control, compared with multimodal analgesia alone. Participants will take study drug before procedure and for 13 days afterwards.
Epistemonikos ID: 6df903137d24974440ec7ae831ba475b6d00d56c
First added on: Oct 09, 2026